Erratum: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells [Cancer Cell Int 16, (2016)(19)] DOI 10.1186/s12935-016-0292-7

Abstract

Upon publication of the original article [1], it was noted that the Core Facilities utilized by the authors for their research were not adequately acknowledged in the manuscript. In this case, the following was mistakenly omitted: Progenitor cell analysis core Molecular Phenotyping core Stem Cell COBRE Grant P30GM106391 Vascular Biology COBRE Grant P30GM103392 This has since been acknowledged and corrected in this erratum.